TY - STD TI - UNAIDS. Global AIDSUpdate 2016. Geneva, Switzerland. Available from: https://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016. Accessed 15 Aug 2018.  UR - https://www.unaids.org/en/resources/documents/2016/Global-AIDS-update-2016 ID - ref1 ER - TY - STD TI - Joint United Nations Programme on HIV/AIDS. Fact sheet—Latest statistics on the status of the AIDS epidemic. 2017. Available from: https://www.unaids.org/en/resources/fact-sheet. Accessed 20 Aug 2018. UR - https://www.unaids.org/en/resources/fact-sheet ID - ref2 ER - TY - STD TI - CSA.Ethiopia Demographic and Health Survey. HIV prevalence report. Central Statistical Authority. 2016;2016. ID - ref3 ER - TY - BOOK AU - Yared, M. AU - Tibebu, S. AU - Emmart, P. PY - 2010 DA - 2010// TI - Equity and access to ART in Ethiopia PB - Future Group, Health Policy Initiative. Task Order I CY - Washington, DC ID - Yared2010 ER - TY - JOUR AU - Assefa, Y. AU - Jerene, D. AU - Lulseged, S. AU - Ooms, G. AU - Damme, W. PY - 2009 DA - 2009// TI - Rapid scale-up of antiretroviral treatment in Ethiopia: successes and system-wide effects JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000056 DO - 10.1371/journal.pmed.1000056 ID - Assefa2009 ER - TY - STD TI - Federal Ministry of Health. Ethiopian National consolidated guidelines for comprehensive HIV prevention, care and treatment. 2018. Available from: https://aidsfree.usaid.gov/resources/ethiopia-national-guidelines-comprehensive-hiv-prevention-care-and-treatment-0. Accessed 10 Aug 2018. UR - https://aidsfree.usaid.gov/resources/ethiopia-national-guidelines-comprehensive-hiv-prevention-care-and-treatment-0 ID - ref6 ER - TY - JOUR AU - Chowers, M. Y. AU - Gottesman, B. S. AU - Leibovici, L. AU - Pielmeier, U. AU - Andreassen, S. AU - Paul, M. PY - 2009 DA - 2009// TI - Reporting of adverse events in randomized controlled trials of highly active antiretroviral therapy: systematic review JO - J Antimicrob Chemother VL - 64 UR - https://doi.org/10.1093/jac/dkp191 DO - 10.1093/jac/dkp191 ID - Chowers2009 ER - TY - JOUR AU - Mills, E. J. AU - Nachega, J. B. AU - Buchan, I. AU - Orbinski, J. AU - Attaran, A. AU - Singh, S. AU - Rachlis, B. AU - Wu, P. AU - Cooper, C. AU - Thabane, L. PY - 2006 DA - 2006// TI - Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis JO - JAMA. VL - 296 UR - https://doi.org/10.1001/jama.296.6.679 DO - 10.1001/jama.296.6.679 ID - Mills2006 ER - TY - JOUR AU - Park, W. B. AU - Choe, P. G. AU - Kim, S. -. H. AU - Jo, J. H. AU - Bang, J. H. AU - Kim, H. B. AU - Kim, N. J. AU - Oh, M. -. D. AU - Choe, K. W. PY - 2007 DA - 2007// TI - Early modification of initial HAART regimen associated with poor clinical outcome in HIV patients JO - AIDS Res Hum Retrovir VL - 23 UR - https://doi.org/10.1089/aid.2006.0255 DO - 10.1089/aid.2006.0255 ID - Park2007 ER - TY - JOUR AU - Elzi, L. AU - Marzolini, C. AU - Furrer, H. AU - Ledergerber, B. AU - Cavassini, M. AU - Hirschel, B. AU - Vernazza, P. AU - Bernasconi, E. AU - Weber, R. AU - Battegay, M. PY - 2010 DA - 2010// TI - Treatment modification in human immunodeficiency virus–infected individuals starting combination antiretroviral therapy between 2005 and 2008 JO - Arch Intern Med VL - 170 UR - https://doi.org/10.1001/archinternmed.2009.432 DO - 10.1001/archinternmed.2009.432 ID - Elzi2010 ER - TY - JOUR AU - Selinger-Leneman, H. AU - Matheron, S. AU - Mahamat, A. AU - Moreau, J. AU - Costagliola, D. AU - Abgrall, S. PY - 2008 DA - 2008// TI - Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy JO - JAIDS. VL - 47 ID - Selinger-Leneman2008 ER - TY - JOUR AU - Hart, E. AU - Curtis, H. AU - Wilkins, E. AU - Johnson, M. PY - 2007 DA - 2007// TI - National review of first treatment change after starting highly active antiretroviral therapy in antiretroviral-naïve patients JO - HIV Med. VL - 8 UR - https://doi.org/10.1111/j.1468-1293.2007.00451.x DO - 10.1111/j.1468-1293.2007.00451.x ID - Hart2007 ER - TY - JOUR AU - Timothy, W. AU - Marshall, G. AU - Roy, M. PY - 2006 DA - 2006// TI - HIV insight knowledge base chapter changing antiretroviral therapy: why, when and how JO - JAIDS. VL - 12 ID - Timothy2006 ER - TY - JOUR AU - Rappold, M. i. c. h. a. e. l. a. AU - Rieger, A. r. m. i. n. AU - Steuer, A. n. d. r. e. a. AU - Geit, M. a. r. i. a. AU - Sarcletti, M. a. r. i. o. AU - Haas, B. e. r. n. h. a. r. d. AU - Taylor, N. i. n. o. n. AU - Kanatschnig, M. a. n. f. r. e. d. AU - Leierer, G. i. s. e. l. a. AU - Ledergerber, B. r. u. n. o. AU - Zangerle, R. o. b. e. r. t. PY - 2014 DA - 2014// TI - Treatment modification in HIV-Infected individuals starting antiretroviral therapy between 2011 and 2014 JO - Journal of the International AIDS Society VL - 17 UR - https://doi.org/10.7448/IAS.17.4.19768 DO - 10.7448/IAS.17.4.19768 ID - Rappold2014 ER - TY - JOUR AU - Jima, Y. T. AU - Angamo, M. T. AU - Wabe, N. -. T. PY - 2013 DA - 2013// TI - Causes for antiretroviral regimen change among HIV/AIDS patients in Addis Ababa JO - Ethiopia Tanzania J Health Res VL - 15 ID - Jima2013 ER - TY - JOUR AU - Blanco, J. AU - Clotet, B. PY - 2013 DA - 2013// TI - Learning from drug changes in antiretroviral therapy JO - AIDS. VL - 27 UR - https://doi.org/10.1097/QAD.0b013e32835c1213 DO - 10.1097/QAD.0b013e32835c1213 ID - Blanco2013 ER - TY - JOUR AU - Kiguba, R. AU - Byakika-Tusiime, J. AU - Karamagi, C. AU - Ssali, F. AU - Mugyenyi, P. AU - Katabira, E. PY - 2007 DA - 2007// TI - Discontinuation and modification of highly active antiretroviral therapy in HIV-infected Ugandans: prevalence and associated factors JO - JAIDS. VL - 45 ID - Kiguba2007 ER - TY - JOUR AU - Gilks, C. h. a. r. l. e. s. F. AU - Crowley, S. i. o. b. h. a. n. AU - Ekpini, R. e. n. é. AU - Gove, S. a. n. d. y. AU - Perriens, J. o. s. AU - Souteyrand, Y. v. e. s. AU - Sutherland, D. o. n. AU - Vitoria, M. a. r. c. o. AU - Guerma, T. e. g. u. e. s. t. AU - De Cock, K. e. v. i. n. PY - 2006 DA - 2006// TI - The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings JO - The Lancet VL - 368 UR - https://doi.org/10.1016/S0140-6736(06)69158-7 DO - 10.1016/S0140-6736(06)69158-7 ID - Gilks2006 ER - TY - STD TI - WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. Geneva: World Health Organization; 2010. Available from: https://www.who.int/hiv/pub/arv/adult2010/en/. Accessed 23 July 2018. UR - https://www.who.int/hiv/pub/arv/adult2010/en/ ID - ref19 ER - TY - STD TI - Frehiwot N, Mizan K, Seble M, Fethia K, Tekalign M, Zelalem T. National guidelines for comprehensive HIV prevention, care and treatment. Addis Ababa Ministry of Health. 2014. ID - ref20 ER - TY - JOUR AU - Church, K. AU - Kiweewa, F. AU - Dasgupta, A. AU - Mwangome, M. AU - Mpandaguta, E. AU - Gómez-Olivé, F. X. AU - Oti, S. AU - Todd, J. AU - Wringe, A. AU - Geubbels, E. PY - 2015 DA - 2015// TI - A comparative analysis of national HIV policies in six African countries with generalized epidemics JO - Bull World Health Organ VL - 93 UR - https://doi.org/10.2471/BLT.14.147215 DO - 10.2471/BLT.14.147215 ID - Church2015 ER - TY - STD TI - WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: World Health Organization; 2016. Available from: https://www.who.int/hiv/pub/arv/arv-2016/en/. Accessed 12 Aug 2018. UR - https://www.who.int/hiv/pub/arv/arv-2016/en/ ID - ref22 ER - TY - JOUR AU - Liberati, A. AU - Altman, D. G. AU - Tetzlaff, J. AU - Mulrow, C. AU - Gøtzsche, P. C. AU - Ioannidis, J. P. AU - Clarke, M. AU - Devereaux, P. J. AU - Kleijnen, J. AU - Moher, D. PY - 2009 DA - 2009// TI - The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration JO - PLoS Med VL - 6 UR - https://doi.org/10.1371/journal.pmed.1000100 DO - 10.1371/journal.pmed.1000100 ID - Liberati2009 ER - TY - JOUR AU - Munn, Z. AU - Moola, S. AU - Lisy, K. AU - Riitano, D. AU - Tufanaru, C. PY - 2015 DA - 2015// TI - Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data JO - Int J Evid Based healthcare VL - 13 UR - https://doi.org/10.1097/XEB.0000000000000054 DO - 10.1097/XEB.0000000000000054 ID - Munn2015 ER - TY - JOUR AU - Begg, C. o. l. i. n. B. AU - Mazumdar, M. a. d. h. u. c. h. h. a. n. d. a. PY - 1994 DA - 1994// TI - Operating Characteristics of a Rank Correlation Test for Publication Bias JO - Biometrics VL - 50 UR - https://doi.org/10.2307/2533446 DO - 10.2307/2533446 ID - Begg1994 ER - TY - JOUR AU - Egger, M. AU - Smith, G. D. AU - Schneider, M. AU - Minder, C. PY - 1997 DA - 1997// TI - Bias in meta-analysis detected by a simple, graphical test JO - BMJ. VL - 315 UR - https://doi.org/10.1136/bmj.315.7109.629 DO - 10.1136/bmj.315.7109.629 ID - Egger1997 ER - TY - JOUR AU - Zeleke, A. PY - 2016 DA - 2016// TI - Prevalence of antiretroviral treatment failure and associated factors in HIV infected children on antiretroviral therapy at Gondar University hospital, retrospective cohort study JO - Int J Med Med Sci VL - 8 UR - https://doi.org/10.5897/IJMMS2015.1164 DO - 10.5897/IJMMS2015.1164 ID - Zeleke2016 ER - TY - JOUR AU - Sisay, M. M. AU - Ayele, T. A. AU - Gelaw, Y. A. AU - Tsegaye, A. T. AU - Gelaye, K. A. AU - Melak, M. F. PY - 2018 DA - 2018// TI - Incidence and risk factors of first-line antiretroviral treatment failure among human immunodeficiency virus-infected children in Amhara regional state JO - Ethiopia: a retrospective follow-up study BMJ open VL - 8 ID - Sisay2018 ER - TY - JOUR AU - Tadesse, B. T. AU - Foster, B. A. AU - Jerene, D. AU - Ruff, A. PY - 2017 DA - 2017// TI - Cohort profile: improving treatment of HIV-infected Ethiopian children through better detection of treatment failure in southern Ethiopia JO - BMJ Open VL - 7 UR - https://doi.org/10.1136/bmjopen-2016-013528 DO - 10.1136/bmjopen-2016-013528 ID - Tadesse2017 ER - TY - JOUR AU - Yassin, S. AU - Gebretekle, G. B. PY - 2017 DA - 2017// TI - Magnitude and predictors of antiretroviral treatment failure among HIV-infected children in fiche and Kuyu hospitals, Oromia region, Ethiopia: a retrospective cohort study JO - Pharmacol Res Perspect VL - 5 UR - https://doi.org/10.1002/prp2.296 DO - 10.1002/prp2.296 ID - Yassin2017 ER - TY - STD TI - Wube M, Tesfaye A, Hawaze S. Antiretroviral therapy regimen change among HIV/AIDS patients in Nekemt hospital: a primary Care Hospital in Oromia Regional State, Ethiopia. J App Pharm Sci .2013; 3(08):036–040. ID - ref31 ER - TY - JOUR AU - Anlay, D. Z. AU - Alemayehu, Z. A. AU - Dachew, B. A. PY - 2016 DA - 2016// TI - Rate of initial highly active anti-retroviral therapy regimen change and its predictors among adult HIV patients at University of Gondar Referral Hospital, Northwest Ethiopia: a retrospective follow up study JO - AIDS Res Ther VL - 13 UR - https://doi.org/10.1186/s12981-016-0095-x DO - 10.1186/s12981-016-0095-x ID - Anlay2016 ER - TY - JOUR AU - Addisalem, G. AU - Messay, W. -. M. PY - 2014 DA - 2014// TI - Assessment of highly active antiretroviral therapy outcomes among HIV infected adult patients in Jimma university specialized hospital, Jimma, south West Ethiopia JO - Med Data VL - 6 ID - Addisalem2014 ER - TY - JOUR AU - Mulugeta, A. AU - Chanie, T. PY - 2012 DA - 2012// TI - Cause of antiretroviral drug changes among patients on antiretroviral therapy at the art center in Dessei regional referral hospital JO - Ethiopia Int J Pharm Sci Res VL - 3 ID - Mulugeta2012 ER - TY - JOUR AU - Assefa, D. AU - Hussein, N. PY - 2014 DA - 2014// TI - Reasons for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in Fitche hospital, Oromia JO - Ethiopia Adv Pharmacol Pharm VL - 2 ID - Assefa2014 ER - TY - JOUR AU - Mekonnen, Y. AU - Molla, G. PY - 2014 DA - 2014// TI - Reason for regimen change among HIV patients on initial highly active ARV therapy in Bedele hospital ART clinic JO - Ethiopia J Biotechnol Biosafety VL - 2 ID - Mekonnen2014 ER - TY - JOUR AU - Haile, D. AU - Takele, A. AU - Gashaw, K. AU - Demelash, H. AU - Nigatu, D. PY - 2016 DA - 2016// TI - Predictors of treatment failure among adult antiretroviral treatment (ART) clients in bale zone hospitals JO - South Eastern Ethiopia PloS one VL - 11 UR - https://doi.org/10.1371/journal.pone.0164299 DO - 10.1371/journal.pone.0164299 ID - Haile2016 ER - TY - JOUR AU - Tadesse, W. T. AU - Mekonnen, A. B. AU - Tesfaye, W. H. AU - Tadesse, Y. T. PY - 2014 DA - 2014// TI - Self-reported adverse drug reactions and their influence on highly active antiretroviral therapy in HIV infected patients: a cross sectional study JO - BMC Pharmacol Toxicol VL - 15 UR - https://doi.org/10.1186/2050-6511-15-32 DO - 10.1186/2050-6511-15-32 ID - Tadesse2014 ER - TY - STD TI - Birlie B, Braekers R, Awoke T, Kasim A, Shkedy Z. Multi-state models for the analysis of time-to-treatment modification among HIV patients under highly active antiretroviral therapy in Southwest Ethiopia. BMC Infect Dis. 2017;17. ID - ref39 ER - TY - JOUR AU - Bokore, A. AU - Korme, B. AU - Bayisa, G. PY - 2018 DA - 2018// TI - Determinants of anti-retroviral regimen changes among HIV/AIDS patients of east and west Wollega zone health institutions, Oromia region, West Ethiopia: a cross-sectional study JO - BMC Pharmacol Toxicol VL - 19 UR - https://doi.org/10.1186/s40360-018-0220-7 DO - 10.1186/s40360-018-0220-7 ID - Bokore2018 ER - TY - JOUR AU - Mekonnen, E. AU - Workicho, A. AU - Hussein, N. AU - Feyera, T. PY - 2018 DA - 2018// TI - Reasons and predictors for antiretroviral therapy change among HIV-infected adults at south West Ethiopia JO - BMC Res Note VL - 11 UR - https://doi.org/10.1186/s13104-018-3470-y DO - 10.1186/s13104-018-3470-y ID - Mekonnen2018 ER - TY - JOUR AU - Eshetu, B. AU - Wencheko, E. PY - 2014 DA - 2014// TI - Survival longevity of adult AIDS patients under ART: a case study at Felege Hiwot referral hospital, Bahir Dar JO - Ethiopia Ethiop J Health Dev VL - 28 ID - Eshetu2014 ER - TY - JOUR AU - Kasu, B. AU - Zeleke, G. AU - Gashe, F. PY - 2017 DA - 2017// TI - The reasons for regimen shift among people living with HIV/AIDS in Asella referral hospital JO - Medicine. VL - 6 ID - Kasu2017 ER - TY - JOUR AU - Gebremedhin, L. AU - Birhane, A. PY - 2014 DA - 2014// TI - Reasons for anti-retroviral regimen changes in HIV/AIDS patients of Ayder referral hospital ART clinic, Mekelle JO - Ethiopia Int J Pharma Sci Res VL - 5 ID - Gebremedhin2014 ER - TY - JOUR AU - Teklay, G. AU - Legesse, B. AU - Legesse, M. PY - 2013 DA - 2013// TI - Adverse effects and regimen switch among patients on antiretroviral treatment in a resource limited setting in Ethiopia JO - Aust J Pharm VL - 1 ID - Teklay2013 ER - TY - JOUR AU - Woldemedhin, B. AU - Wabe, N. T. PY - 2012 DA - 2012// TI - The reason for regimen change among HIV/AIDS patients initiated on first line highly active antiretroviral therapy in southern Ethiopia JO - North American J Med Sci VL - 4 UR - https://doi.org/10.4103/1947-2714.92898 DO - 10.4103/1947-2714.92898 ID - Woldemedhin2012 ER - TY - JOUR PY - 2013 DA - 2013// TI - Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 JO - AIDS. VL - 27 ID - ref47 ER - TY - JOUR AU - Keiser, O. l. i. v. i. a. AU - Orrell, C. a. t. h. e. r. i. n. e. AU - Egger, M. a. t. t. h. i. a. s. AU - Wood, R. o. b. i. n. AU - Brinkhof, M. a. r. t. i. n. W. G. AU - Furrer, H. a. n. s. j. a. k. o. b. AU - van Cutsem, G. i. l. l. e. s. AU - Ledergerber, B. r. u. n. o. AU - Boulle, A. n. d. r. e. w. PY - 2008 DA - 2008// TI - Correction: Public-Health and Individual Approaches to Antiretroviral Therapy: Township South Africa and Switzerland Compared JO - PLoS Medicine VL - 5 UR - https://doi.org/10.1371/journal.pmed.0050195 DO - 10.1371/journal.pmed.0050195 ID - Keiser2008 ER - TY - JOUR AU - Volberding, P. A. AU - Deeks, S. G. PY - 2010 DA - 2010// TI - Antiretroviral therapy and management of HIV infection JO - Lancet VL - 376 UR - https://doi.org/10.1016/S0140-6736(10)60676-9 DO - 10.1016/S0140-6736(10)60676-9 ID - Volberding2010 ER - TY - JOUR AU - Sivadasan, A. AU - Abraham, O. AU - Rupali, P. AU - Pulimood, S. A. AU - Rajan, J. AU - Rajkumar, S. AU - Zachariah, A. AU - Kannangai, R. AU - Kandathip, A. AU - Sridharan, G. PY - 2009 DA - 2009// TI - High rates of regimen change due to drug toxicity among a cohort of south Indian adults with HIV infection initiated on generic, first-line antiretroviral treatment JO - J Assoc Physicians India VL - 57 ID - Sivadasan2009 ER - TY - JOUR AU - Monforte, A. A. AU - Lepri, A. C. PY - 2000 DA - 2000// TI - Rezza G, Pezzotti P, Antinori a, Phillips AN, Angarano G, Colangeli V, De Luca a, Ippolito G. insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naive patients JO - AIDS. VL - 14 UR - https://doi.org/10.1097/00002030-200003310-00005 DO - 10.1097/00002030-200003310-00005 ID - Monforte2000 ER - TY - JOUR AU - Wilkin, T. AU - Glesby, M. AU - Gulick, R. M. PY - 2006 DA - 2006// TI - Switching antiretroviral therapy: why, when and how JO - IAPAC monthly VL - 12 ID - Wilkin2006 ER - TY - JOUR AU - Günthard, H. F. AU - Aberg, J. A. AU - Eron, J. J. AU - Hoy, J. F. AU - Telenti, A. AU - Benson, C. A. AU - Burger, D. M. AU - Cahn, P. AU - Gallant, J. E. AU - Glesby, M. J. PY - 2014 DA - 2014// TI - Antiretroviral treatment of adult HIV infection: 2014 recommendations of the international antiviral society–USA panel JO - JAMA. VL - 312 UR - https://doi.org/10.1001/jama.2014.8722 DO - 10.1001/jama.2014.8722 ID - Günthard2014 ER - TY - STD TI - UNAIDS. 90‐90‐90, on the right track towards the global target. 2016. Geneva, Switzerland. Available from: https://reliefweb.int/sites/reliefweb.int/files/resources/90_90_90_Progress_ReportFINAL.pdf. Accessed 26 Aug 2018. UR - https://reliefweb.int/sites/reliefweb.int/files/resources/90_90_90_Progress_ReportFINAL.pdf ID - ref54 ER - TY - JOUR AU - Ammassari, A. AU - Murri, R. AU - Pezzotti, P. AU - Trotta, M. P. AU - Ravasio, L. AU - De, P. L. AU - Lo, S. C. AU - Narciso, P. AU - Pauluzzi, S. AU - Carosi, G. PY - 2001 DA - 2001// TI - Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection JO - JAIDS. VL - 28 ID - Ammassari2001 ER - TY - JOUR AU - Cesar, C. AU - Shepherd, B. E. AU - Krolewiecki, A. J. AU - Fink, V. I. AU - Schechter, M. AU - Tuboi, S. H. AU - Wolff, M. AU - Pape, J. W. AU - Leger, P. AU - Padgett, D. PY - 2010 DA - 2010// TI - Rates and reasons for early change of first HAART in HIV-1-infected patients in 7 sites throughout the Caribbean and Latin America JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0010490 DO - 10.1371/journal.pone.0010490 ID - Cesar2010 ER - TY - JOUR AU - O’brien, M. E. AU - Clark, R. A. AU - Besch, C. L. AU - Myers, L. AU - Kissinger, P. PY - 2003 DA - 2003// TI - Patterns and correlates of discontinuation of the initial HAART regimen in an urban outpatient cohort JO - JAIDS. VL - 34 ID - O’brien2003 ER - TY - JOUR AU - Landier, J. AU - Akonde, A. AU - Pizzocolo, C. AU - Haidara, I. AU - Drabo, M. AU - Pizarro, L. AU - Fontanet, A. AU - Katlama, C. AU - Madec, Y. PY - 2011 DA - 2011// TI - Switch to second-line ART in west African routine care: incidence and reasons for switching JO - AIDS Care VL - 23 UR - https://doi.org/10.1080/09540121.2010.498867 DO - 10.1080/09540121.2010.498867 ID - Landier2011 ER - TY - JOUR AU - Hoffmann, C. J. AU - Charalambous, S. AU - Thio, C. L. AU - Martin, D. J. AU - Pemba, L. AU - Fielding, K. L. AU - Churchyard, G. J. AU - Chaisson, R. E. AU - Grant, A. D. PY - 2007 DA - 2007// TI - Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B JO - AIDS. VL - 21 UR - https://doi.org/10.1097/QAD.0b013e32814e6b08 DO - 10.1097/QAD.0b013e32814e6b08 ID - Hoffmann2007 ER - TY - JOUR AU - Hill, S. AU - Kavookjian, J. AU - Qian, J. AU - Chung, A. AU - Vandewaa, J. PY - 2014 DA - 2014// TI - Effects of pill burden on discontinuation of the initial HAART regimen in minority female patients prescribed 1 pill/day versus any other pill burden JO - AIDS Care VL - 26 UR - https://doi.org/10.1080/09540121.2013.844766 DO - 10.1080/09540121.2013.844766 ID - Hill2014 ER - TY - JOUR AU - Aldous, J. L. AU - Haubrich, R. H. PY - 2009 DA - 2009// TI - Defining treatment failure in resource-rich settings JO - Curr Opin HIV AIDS VL - 4 UR - https://doi.org/10.1097/COH.0b013e328331dea5 DO - 10.1097/COH.0b013e328331dea5 ID - Aldous2009 ER - TY - JOUR AU - Cozzi-Lepri, A. AU - Paredes, R. AU - Phillips, A. AU - Clotet, B. AU - Kjær, J. AU - Wyl, V. AU - Kronborg, G. AU - Castagna, A. AU - Bogner, J. AU - Lundgren, J. PY - 2012 DA - 2012// TI - The rate of accumulation of nonnucleoside reverse transcriptase inhibitor (NNRTI) resistance in patients kept on a virologically failing regimen containing an NNRTI JO - HIV Med VL - 13 ID - Cozzi-Lepri2012 ER - TY - STD TI - Pillay D, Kityo C, Robertson V, Lyagoba F, Dunn D, Tugume S. Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of combivir/tenofovir within the DART trial. 4th IAS Conference on HIV Pathogenesis, Treatment, and Prevention. 22-25 July 2007, Sydney, Australia. Poster 642. ID - ref63 ER - TY - STD TI - Federal Ministry of Health. Guidelines for use of antiretroviral drugs in Ethiopia. Addis Ababa: Federal Ministry of Health; 2005. ID - ref64 ER - TY - JOUR AU - Ford, N. AU - Calmy, A. AU - Mofenson, L. PY - 2011 DA - 2011// TI - Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis JO - AIDS. VL - 25 UR - https://doi.org/10.1097/QAD.0b013e32834cdb71 DO - 10.1097/QAD.0b013e32834cdb71 ID - Ford2011 ER -